Cognate BioServices cognatebioservices.com


Public lists: Pharma Startups (4732)

Cognate BioServices, fka Cognate Therapeutics, is a fully-integrated contract bioservices organization providing scientific and management expertise. Cognate provides full development and cGMP manufacturing services to companies and institutions engaged in the development and manufacture of cell-based products.

Cognate BioServices, fka Cognate Therapeutics, is a fully-integrated contract bioservices organization providing scientific and management expertise. Cognate provides full development and cGMP manufacturing services to companies and institutions enga...Show all

Company (Alive / Active)

Phone: 901-541-9800

Fax:

7513 Connelley Drive
Suite I
Hanover, 21076
Maryland, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Cognate BioServices $0M Feb 20, 2018
See all 21 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Cognate BioServices Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 4 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Pieris

Boston, Massachusetts, United States
IPO / Went publicPieris is an independent, clinical-staged biotechnology company advancing its proprietary Anticalin technology to create differentiated drugs that are safer and more effective than conventional approaches. Exclusive to Pieris, Anticalins promise to address high-unmet medical needs and expand the potential of targeted therapeutics. The company currently has a diverse proprietary pipeline and has ongoing R&D collaborations with Daiichi Sankyo, the Sanofi Group, Zydus Cadila, Stelis Biopharma and A...Show allLogin to see details

Inotek Pharmaceuticals

Lexington, Massachusetts, United States
IPO / Went publicInotek Pharmaceuticals is a biotechnology company focused on the discovery and development of drugs to address serious diseases of the eye. Inotek scientists have identified a deep pipeline of drug candidates to ameliorate inflammation, ischemia-reperfusion injury, and oxidative stress, which are key targets for drugs to treat Glaucoma, Ocular Hypertension, Age-related Macular Degeneration and Retinal Neuropathies. The Company's lead program, trabodenoson (INO-8875) is a highly selective adenosi...Show allLogin to see details
See all 21 competitors